Expanding Use of the HeartMate 3 VAD in Pediatric and Adult Patients within the ACTION
ACTION set forth to report current outcomes in patients supported with the HeartMate 3 ventricular assist device in a multicenter learning network.
ACTION set forth to report current outcomes in patients supported with the HeartMate 3 ventricular assist device in a multicenter learning network.
Tthe 2022 ACT-VAD Registry Data Report highlights our VAD registry data findings from April 2018 thru December 2022.
Check out the newest One Page Summary (OPS) featuring the Berlin Heart EXCOR® Active This OPS includes an overview of the device pump settings, system preferences, pump optimization, power sources, accessories, alarms …
Check out the newest One Page Summary (OPS) featuring the Abiomed Impella® This OPS includes an overview of the device size selection, system components, pump settings, waveforms, as well as highlighting anticoagulation, …
Individuals with Fontan circulation are at risk of late mortality from both cardiac and noncardiac causes. Despite the known risk of mortality, referral indications for advanced heart failure care vary …
Check out the newest One Page Summary (OPS) featuring the SynCardia (TAH-t). The OPS includes device size selection, components, function, settings and readings, as well as highlighting anticoagulation, blood pressure, …
Patient- and proxy-reported outcomes (PROs) are an important indicator of healthcare quality but are underutilised in paediatric cardiac care. This ACTION study, Patient and parent-reported outcomes in paediatric ventricular assist …
ACTION Learning Network investigators recently published Ventricular Assist Device Outcomes in Infants and Children With Stage 1 Single Ventricle Palliation in the November 2022 issue of the ASAIO Journal. Examining …
Check out the Berlin Heart One Page Summary (OPS). This OPS includes pump settings and function, cannulation strategies, blood pump and system components, power sources, as well as highlighting anticoagulation, …
Purpose Cardiac disease results in significant morbidity and mortality in patients with muscular dystrophy (MD). Single centers have reported their ventricular assist device (VAD) experience in specific MDs and in …